Glycyrrhizin (GU-01)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glycyrrhizin (GU-01), covering 2026-02-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: GU-01: Glycyrrhizin in Prostate Cancer [Phase 2]